Evidence map›Paper›PMID 27829022›Full record

ArticlePloS one2016

Inhibition of Cholera Toxin and Other AB Toxins by Polyphenolic Compounds.

Patrick Cherubin, Maria Camila Garcia, David Curtis, Christopher B T Britt, John W Craft, Helen Burress, Chris Berndt, Srikar Reddy, Jessica Guyette, Tianyu Zheng and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Anti-Cholera toxin activity of selected polyphenols fromFrontiers in cellular and infection microbiology · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. A Comprehensive Study on the Antimicrobial Properties of Resveratrol as an Alternative Therapy.Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Patrick CherubinBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America.
Maria Camila GarciaBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America.
David CurtisBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America.
Christopher B T BrittBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America.
John W CraftDepartment of Biology & Biochemistry, University of Houston, Houston, Texas, United States of America.
Helen BurressBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America.
Chris BerndtBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America.
Srikar ReddyBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America.
Jessica GuyetteBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America.
Tianyu ZhengNanoScience Technology Center and Department of Chemistry, University of Central Florida, Orlando, Florida, United States of America.
Qun HuoNanoScience Technology Center and Department of Chemistry, University of Central Florida, Orlando, Florida, United States of America.
Beatriz QuiñonesProduce Safety and Microbiology Research Unit, Western Regional Research Center, United States Department of Agriculture - Agricultural Research Service, Albany, California, United States of America.
James M BriggsDepartment of Biology & Biochemistry, University of Houston, Houston, Texas, United States of America.
Ken TeterBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America.ORCID http://orcid.org/0000-0003-4176-9361
University of Central Florida · USUniversity of Houston · USAgricultural Research Service · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholera toxin (CT) is an AB-type protein toxin that contains a catalytic A1 subunit, an A2 linker, and a cell-binding B homopentamer. The CT holotoxin is released into the extracellular environment, but CTA1 attacks a target within the cytosol of a host cell. We recently reported that grape extract confers substantial resistance to CT. Here, we used a cell culture system to identify twelve individual phenolic compounds from grape extract that inhibit CT. Additional studies determined the mechanism of inhibition for a subset of the compounds: two inhibited CT binding to the cell surface and even stripped CT from the plasma membrane of a target cell; two inhibited the enzymatic activity of CTA1; and four blocked cytosolic toxin activity without directly affecting the enzymatic function of CTA1. Individual polyphenolic compounds from grape extract could also generate cellular resistance to diphtheria toxin, exotoxin A, and ricin. We have thus identified individual toxin inhibitors from grape extract and some of their mechanisms of inhibition against CT.

Indexed as

ADP Ribose TransferasesAnimalsBacterial ToxinsBiflavonoidsBinding SitesCatechinCell MembraneCells, CulturedChlorocebus aethiopsCHO CellsCholera ToxinCricetulusDiphtheria ToxinExotoxinsFruitGrape Seed ExtractADP Ribose TransferasesBacterial ToxinsBiflavonoidsCatechinCholera ToxinDiphtheria Toxinepigallocatechin gallateExotoxinsGrape Seed ExtractPhenolsPlant ExtractsProanthocyanidinsprocyanidin B2Pseudomonas aeruginosa Exotoxin ARicinVirulence Factors

Identifiers

PMID27829022
PMCPMC5102367
OpenAlexW2550051678

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.